Barely Significant
← all excerpts

Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC.

J Immunother Cancer · 2024 · PMC11667274 · PMID 39706602

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Furthermore, the cytotoxic function and proliferation of CD8 + PD-1 + T cells, which are considered to be highly enriched in antigen-specific T cells, 29 showed a trend similar to that of CD8 + T cells ( figure 4E , online supplemental figure 3E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.